VEGF and HIF-1α expression are increased in advanced stages of epithelial ovarian cancer
- 1 December 2003
- journal article
- Published by Elsevier BV in Gynecologic Oncology
- Vol. 91 (3), 513-517
- https://doi.org/10.1016/j.ygyno.2003.08.022
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Thymidine phosphorylase-mediated angiogenesis regulated by thymidine phosphorylase inhibitor in human ovarian cancer cells in vivo.International Journal of Oncology, 2003
- Stabilization of Vascular Endothelial Growth Factor mRNA by Hypoxia-Inducible Factor 1Biochemical and Biophysical Research Communications, 2002
- Dual mechanism of vascular endothelial growth factor upregulation by hypoxia in human hepatocellular carcinomaGut, 2001
- Vessel Cooption, Regression, and Growth in Tumors Mediated by Angiopoietins and VEGFScience, 1999
- HIF-1alpha is required for solid tumor formation and embryonic vascularizationThe EMBO Journal, 1998
- Activation of Vascular Endothelial Growth Factor Gene Transcription by Hypoxia-Inducible Factor 1Molecular and Cellular Biology, 1996
- Patterns and Emerging Mechanisms of the Angiogenic Switch during TumorigenesisCell, 1996
- Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension.Proceedings of the National Academy of Sciences, 1995
- Enhancement of Tumor Growth and Vascular Density by Transfection of Vascular Endothelial Cell Growth Factor Into MCF-7 Human Breast Carcinoma CellsJNCI Journal of the National Cancer Institute, 1995
- Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesisNature, 1992